Primary Job Title CEO & President Primary Organization 
SG Austria
Location Singapore, Central Region, Singapore Regions Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia Gender Male
LinkedIn View on LinkedIn
Brian Salmons received his Ph.D. in London and after research positions in the U.S.A., Switzerland and at the Ludwig Maximilian University, Munich, Germany, he became the Scientific Director of the European biotech/vaccine company, Bavarian Nordic, and was involved in taking the company to IPO.
During this time, Brian co-invented the
“Cell-in-a-Box®” live-cell encapsulation technology that was shown to be safe and efficacious in a Phase I/II clinical trial published in The Lancet.
In 2002, he co-founded the Biotech company, Austrianova, originally a spin out of the Veterinary Medicine University in Vienna and was instrumental in obtaining orphan drug status from the European Medicines Agency for its lead cell encapsulation product to treat pancreatic cancer.
In 2007, Brian co-founded and became the CEO of Austrianova Singapore Pte Ltd, an independent company established in Singapore to further develop the encapsulation technology as products for a variety of indications such as various forms of cancer, diabetes, neurodegenerative, cardiovascular and infectious diseases.
Brian is the author or co-author of over 120 peer reviewed scientific articles and inventor of 8 patent families.
